Welcome to Gyre Therapeutics Our Science Hydronidone MASH Other Disease Areas Latest news Mar 17, 2025 Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Read more Jan 06, 2025 Gyre Therapeutics Announces the Appointment of Ping Zhang to Board ...
快讯| 尤瑞公司报告称,截至9月6日,罗英持有Gyre Therapeutics 8.54%的股份-SEC文件 快讯09/06 20:17 Gyre Therapeutics将在H.C. Wainwright第26届年度全球投资大会上进行演讲。 2024年9月4日圣地亚哥 (GLOBE NEWSWIRE) -- Gyre Therapeutics(“Gyre”)(纳斯达克: GYRE),一家自给自足的商业化生物技术公司,致力于...
快讯| 尤瑞公司报告称,截至9月6日,罗英持有Gyre Therapeutics 8.54%的股份-SEC文件 快讯09/06 20:17 Gyre Therapeutics将在H.C. Wainwright第26届年度全球投资大会上进行演讲。 2024年9月4日圣地亚哥 (GLOBE NEWSWIRE) -- Gyre Therapeutics(“Gyre”)(纳斯达克: GYRE),一家自给自足的商业化生物技术公司,致力于...
Gyre Therapeutics, Inc. (GYRE) posted a net loss of $85.5 million for the full year ended December 31, 2023, compared to net income of $4.3 million, last year. Net loss per share was $1.
Latest GYRE News Stocks Insider Sale: President of $GYRE Sells 1,878 Shares Feb 12, 2025•Quiver Quantitative Markets Gyre Therapeutics Shares Cross Above 200 DMA Feb 5, 2025•BNK Invest Stocks Leadership Changes at Gyre Therapeutics Amid Strategic Shift ...
圣地亚哥——根据InvestingPro的数据,Gyre Therapeutics, Inc.(纳斯达克代码:GYRE)总裁马松江最近出售了其持有的部分公司股票。该股票在过去一周表现强劲,上涨了13.62%。根据向美国证券交易委员会提交的文件,松江于1月14日和1月15日进行了两次单独的交易,总共出售了4,000股普通股。
据SEC文件显示,市值11亿美元、流动比率为3.72的生物科技公司Gyre Therapeutics, Inc. (NASDAQ:GYRE)总裁马松江报告出售了价值48,029美元的股票。交易发生在2025年2月4日和5日,共涉及4,000股普通股。售价在每股11.62美元至12.84美元之间。 此次出售是根据Rule 10b5-1交易计划进行的,该计划允许内部人士制定预定的股票...
And free real time news catalyst alerts! Edge DonCorleone77Mar 18, 2025 4:32 AM $GYRE Gyre Therapeutics reports Q4 EPS 0c vs. ($1.39) last year Reports Q4 revenue $27.87M consensus $23.5M. "2025 is shaping up to be a pivotal year for Gyre across both our commercial-stage and ...
All Analysis News SEC Filings Press Releases Related Analysis GYRE Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -18.89% Gyre Therapeutics, Inc. price and volume Combination chart with 2 data series. Chart represents Gyre Therapeutics, Inc. price and volume over 1Y period The ...
Gyre Therapeutics Inc. Annual stock financials by MarketWatch. View the latest GYRE financial statements, income statements and financial ratios.